Cellectis (CLLS) Gross Margin Growth (1y) (2016 - 2023)

Cellectis (CLLS) Gross Margin Growth (1y) (2016 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Cellectis 281.48 Mn 95.81 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 22,129.00
Sep 30, 2023 -2,706.00
Jun 30, 2023 -573.00
Mar 31, 2023 -14,221.00
Dec 31, 2022 86.00
Sep 30, 2022 -9,887.00
Jun 30, 2022 8,000.00
Mar 31, 2022 1,107.00
Dec 31, 2021 3,600.00
Sep 30, 2021 1,572.00
Jun 30, 2021 9,576.00
Mar 31, 2021 -9,998.00
Dec 31, 2020 -881.00
Sep 30, 2020 -7,641.00
Jun 30, 2020 -13,018.00
Mar 31, 2020 4,739.00
Dec 31, 2019 -5,341.00
Sep 30, 2019 4,566.00
Jun 30, 2019 -6,405.00
Mar 31, 2019 -4,698.00